AR061165A1 - Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas - Google Patents
Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticasInfo
- Publication number
- AR061165A1 AR061165A1 ARP070102383A ARP070102383A AR061165A1 AR 061165 A1 AR061165 A1 AR 061165A1 AR P070102383 A ARP070102383 A AR P070102383A AR P070102383 A ARP070102383 A AR P070102383A AR 061165 A1 AR061165 A1 AR 061165A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenylephrine
- component
- pharmaceutical composition
- phenylefrine
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente describe una formulacion de liberacion pulsada o una composicion farmacéutica que comprende fenilefrina. La composicion farmacéutica comprende un componente de liberacion inmediata y un componente con recubrimiento entérico formulados conjuntamente ya sea en forma solida o en una suspension. El componente de la cubierta entérica comprende microcristales sembrados con fenilefrina como componente activo y recubierto con una cubierta sensible al pH para retardar la liberacion de la fenilefrina. La composicion farmacéutica puede comprender además por lo menos un componente activo seleccionado del grupo que consiste en un antihistamínico, un analgésico, un antipirético, un anti-inflamatorio no esteroide y mezclas de dos o más de dichos componentes activos. Reivindicacion 20: Un método de preparacion de una composicion de acuerdo con la reivindicacion 2, que comprende mezclar microcristales con cubierta entérica que contienen fenilefrina, fenilefrina a granel y un líquido.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81001806P | 2006-06-01 | 2006-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR061165A1 true AR061165A1 (es) | 2008-08-06 |
Family
ID=38582318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070102383A AR061165A1 (es) | 2006-06-01 | 2007-06-01 | Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070281019A1 (es) |
EP (1) | EP2029105A1 (es) |
JP (1) | JP2009538919A (es) |
KR (1) | KR20090015103A (es) |
CN (1) | CN101472561A (es) |
AR (1) | AR061165A1 (es) |
AU (1) | AU2007254819A1 (es) |
CA (1) | CA2653950A1 (es) |
MX (1) | MX2008015357A (es) |
NO (1) | NO20085416L (es) |
PE (1) | PE20080313A1 (es) |
RU (1) | RU2008151945A (es) |
TW (1) | TW200808376A (es) |
WO (1) | WO2007143156A1 (es) |
ZA (1) | ZA200810162B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8940796B2 (en) | 2006-02-21 | 2015-01-27 | Wyeth Llc | Phenylephrine liquid formulations |
US9005652B2 (en) | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
EP2385823A4 (en) * | 2009-01-09 | 2014-02-12 | Panacea Biotec Ltd | DOUBLE RELEASE PHARMACEUTICAL SUSPENSION |
MX2009001925A (es) * | 2009-02-20 | 2010-08-20 | Senosiain S A De C V Lab | Composicion farmaceutica oral para uso en enfermedades respiratorias. |
BR112017005574A2 (pt) * | 2014-09-19 | 2017-12-12 | Procter & Gamble | formas de dosagem de liberação pulsada de fenilefrina |
US10278930B2 (en) | 2017-03-16 | 2019-05-07 | The Procter & Gamble Company | Method for relieving sinus congestion |
CN109875966B (zh) * | 2019-04-09 | 2021-03-26 | 海南普利制药股份有限公司 | 地氯雷他定干混悬剂 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2085865A (en) * | 1931-07-29 | 1937-07-06 | Morrison Simon | Lipstick holder |
US3558768A (en) * | 1969-12-19 | 1971-01-26 | Sterling Drug Inc | Sustained release pharmaceutical compositions |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
US5025019A (en) * | 1984-04-09 | 1991-06-18 | Analgesic Associates | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
DE69107461T2 (de) * | 1990-08-07 | 1995-06-22 | Pfizer | Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen. |
US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
US6160020A (en) * | 1996-12-20 | 2000-12-12 | Mcneill-Ppc, Inc. | Alkali metal and alkaline-earth metal salts of acetaminophen |
MX9701946A (es) * | 1997-03-14 | 1998-04-30 | Arturo Jimenez Bayardo | Solucion oftalmica transportadora. |
EP1021204B1 (en) * | 1997-09-26 | 2005-12-28 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
US6602521B1 (en) * | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
US6521254B2 (en) * | 1998-12-07 | 2003-02-18 | J-Med Pharmaceuticals, Inc. | Single-dose antihistamine/decongestant formulations for treating rhinitis |
CN1161112C (zh) * | 1999-02-23 | 2004-08-11 | 株式会社柳韩洋行 | 含氯雷他定和伪麻黄碱的药物胶囊组合物 |
US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
US6114346A (en) * | 1999-10-22 | 2000-09-05 | Schering Corporation | Treating sleep disorders using desloratadine |
AU2276801A (en) * | 1999-12-20 | 2001-07-03 | Schering Corporation | Extended release oral dosage composition |
WO2001045668A2 (en) * | 1999-12-20 | 2001-06-28 | Schering Corporation | Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
US6955821B2 (en) * | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
AU2001261744A1 (en) * | 2000-05-19 | 2001-12-03 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
WO2002036077A2 (en) * | 2000-11-06 | 2002-05-10 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
US20030236275A1 (en) * | 2002-06-20 | 2003-12-25 | Schering Corporation | Treatment methods of nasal congestion and nasal obstruction |
US7163696B2 (en) * | 2001-10-11 | 2007-01-16 | Pfizer Inc. | Pharmaceutical formulations |
US20030083354A1 (en) * | 2001-10-26 | 2003-05-01 | Pediamed Pharmaceuticals, Inc. | Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions |
US7101572B2 (en) * | 2001-12-07 | 2006-09-05 | Unilab Pharmatech, Ltd. | Taste masked aqueous liquid pharmaceutical composition |
US20030114535A1 (en) * | 2001-12-14 | 2003-06-19 | Jame Fine Chemicals, Inc. | Dextrochlorpheniramine tannate |
US6979689B2 (en) * | 2002-12-20 | 2005-12-27 | Pediamed Pharmaceuticals, Inc. | Compositions and methods for treating upper respiratory congestion |
US20040214215A1 (en) * | 2003-03-07 | 2004-10-28 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
US20050152967A1 (en) * | 2003-03-28 | 2005-07-14 | Pfab, Lp | Dynamic variable release |
US20050026890A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease |
US20050095288A1 (en) * | 2003-11-03 | 2005-05-05 | Andrx Labs, Llc | Decongestant and expectorant tablets |
US20050266032A1 (en) * | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
US9492541B2 (en) * | 2004-09-14 | 2016-11-15 | Sovereign Pharmaceuticals, Llc | Phenylepherine containing dosage form |
EP1874275A1 (en) * | 2004-12-13 | 2008-01-09 | McNEIL-PPC, INC. | Compositons and methods for stabilizing active pharmaceutical ingredients |
US8940796B2 (en) * | 2006-02-21 | 2015-01-27 | Wyeth Llc | Phenylephrine liquid formulations |
US20080014274A1 (en) * | 2006-07-14 | 2008-01-17 | Wyeth | Enhanced stability phenylephrine liquid compositions |
US9005652B2 (en) * | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
US7378082B1 (en) * | 2007-11-05 | 2008-05-27 | Inspire Pharmaceuticals, Inc. | Method for treating allergic rhinitis without adverse effects |
-
2007
- 2007-06-01 AU AU2007254819A patent/AU2007254819A1/en not_active Abandoned
- 2007-06-01 US US11/756,769 patent/US20070281019A1/en not_active Abandoned
- 2007-06-01 AR ARP070102383A patent/AR061165A1/es not_active Application Discontinuation
- 2007-06-01 TW TW096119769A patent/TW200808376A/zh unknown
- 2007-06-01 KR KR1020087029356A patent/KR20090015103A/ko not_active Application Discontinuation
- 2007-06-01 JP JP2009513317A patent/JP2009538919A/ja not_active Withdrawn
- 2007-06-01 CN CNA2007800200398A patent/CN101472561A/zh active Pending
- 2007-06-01 CA CA002653950A patent/CA2653950A1/en not_active Abandoned
- 2007-06-01 RU RU2008151945/15A patent/RU2008151945A/ru not_active Application Discontinuation
- 2007-06-01 PE PE2007000687A patent/PE20080313A1/es not_active Application Discontinuation
- 2007-06-01 WO PCT/US2007/013048 patent/WO2007143156A1/en active Application Filing
- 2007-06-01 EP EP07777372A patent/EP2029105A1/en not_active Withdrawn
- 2007-06-01 MX MX2008015357A patent/MX2008015357A/es not_active Application Discontinuation
-
2008
- 2008-11-28 ZA ZA200810162A patent/ZA200810162B/xx unknown
- 2008-12-30 NO NO20085416A patent/NO20085416L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20085416L (no) | 2008-12-30 |
TW200808376A (en) | 2008-02-16 |
US20070281019A1 (en) | 2007-12-06 |
EP2029105A1 (en) | 2009-03-04 |
AU2007254819A1 (en) | 2007-12-13 |
PE20080313A1 (es) | 2008-04-10 |
ZA200810162B (en) | 2009-11-25 |
JP2009538919A (ja) | 2009-11-12 |
MX2008015357A (es) | 2009-03-06 |
CN101472561A (zh) | 2009-07-01 |
KR20090015103A (ko) | 2009-02-11 |
RU2008151945A (ru) | 2010-07-20 |
CA2653950A1 (en) | 2007-12-13 |
WO2007143156A1 (en) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR061165A1 (es) | Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas | |
AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
PE20080765A1 (es) | Formas de dosificacion farmaceutica | |
AR061289A1 (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
EA201071054A1 (ru) | Твердый препарат, растворяющийся во рту | |
BRPI0606883A2 (pt) | composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única | |
UY30107A1 (es) | Nuevos derivados de pirimidina, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
PE20140960A1 (es) | Formulaciones que comprenden un inhibidor de dpp4 | |
AR067495A1 (es) | Composiciones farmaceuticas y procedimientode tratamientos de trastornos de ojo seco | |
BRPI0709581A8 (pt) | compostos de bicicloeteroarila como moduladores de px27 e seu uso | |
ECSP088800A (es) | Formulaciones de inhibidores de DPP IV | |
PE20061091A1 (es) | FORMA CRISTALINA BETA-d DEL CLORHIDRATO DE IVABRANDINA, SU PROCEDIMIENTO DE PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN | |
CO6321225A2 (es) | Particulas portadoras sólidas para mejorar la procesabilidad de un agente farmacéutico | |
BR112012008317A2 (pt) | produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal | |
BRPI0414581C1 (pt) | composto, composição farmacêutica compreendendo o referido composto e uso do referido composto | |
BR112012006686B8 (pt) | compostos de amida substituída, composições farmacêuticas contendo os ditos compostos, e uso dos mesmos para prevenir e/ou tratar doenças causadas pelo lpa | |
CO6300932A2 (es) | Composicion solida termoestable que comprende sustancias mejoradas de permeabilidad para ingredientes farmaceuticos activos de permeabilidad deficiente | |
NO20081628L (no) | Benzodiazepiner som HCV-inhibitorer | |
BRPI0909055A2 (pt) | composto derivado de piridin-2-il, composição farmacêutica que o contém e uso desse composto. | |
UY30215A1 (es) | Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones | |
BR112014009438A2 (pt) | composição farmacêutica para administração oral, e, método de preparação da composição farmacêutica para administração oral | |
ECSP067050A (es) | Forma de dosificacion solida de heparina humeda | |
BR112013004455A2 (pt) | composições para fornecimento gástrico de agentes ativos | |
MX2012005689A (es) | Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos. | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |